<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0038013" disease_type="Disease or Syndrome" abbrv="">Ankylosing spondylitis</z:e>, indefinite juvenile <z:e sem="disease" ids="C0949690" disease_type="Disease or Syndrome" abbrv="">spondyloarthritis</z:e> (JSA), <z:e sem="disease" ids="C0085435" disease_type="Disease or Syndrome" abbrv="">reactive arthritides</z:e>, <z:hpo ids='HP_0003765'>psoriasis</z:hpo> <z:hpo ids='HP_0001369'>arthritis</z:hpo>, <z:hpo ids='HP_0001369'>arthritis</z:hpo> of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e>, and probably other <z:e sem="disease" ids="C0678236" disease_type="Disease or Syndrome" abbrv="">rare diseases</z:e>, such as the <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et-syndrome, are sharing several distinctive features which discriminate them as a group from <z:e sem="disease" ids="C0494904" disease_type="Disease or Syndrome" abbrv="">other arthritides</z:e>, particularly from the <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> in children (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e>) and adults </plain></SENT>
<SENT sid="1" pm="."><plain>These distinctive features are: familial aggregation; association with HLA-B27; <z:e sem="disease" ids="C0242490" disease_type="Disease or Syndrome" abbrv="">enthesopathy</z:e>, <z:e sem="disease" ids="C0574960" disease_type="Disease or Syndrome" abbrv="">sacroiliitis</z:e>; predominance of Lower-Limb-<z:hpo ids='HP_0001369'>arthritis</z:hpo>; <z:hpo ids='HP_0003674'>onset</z:hpo> mostly after the age of 10 years, and typical manifestations of the skin and mucous membranes </plain></SENT>
<SENT sid="2" pm="."><plain>Based on these characteristics and the probability of a later involvement of the spine, this group of diseases has been designated "HLA-B27-associated <z:e sem="disease" ids="C0949690" disease_type="Disease or Syndrome" abbrv="">spondyloarthritides</z:e>" </plain></SENT>
<SENT sid="3" pm="."><plain>Two thirds of <z:hpo ids='HP_0000001'>all</z:hpo> cases do not fit in any of the well-known <z:e sem="disease" ids="C0949690" disease_type="Disease or Syndrome" abbrv="">spondyloarthritides</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In this subgroup, designated as JSA, the disease begins usually with <z:e sem="disease" ids="C0409702" disease_type="Disease or Syndrome" abbrv="">oligoarthritis</z:e> and/or <z:e sem="disease" ids="C0242490" disease_type="Disease or Syndrome" abbrv="">enthesopathy</z:e>, and based on further clinical criteria it can early be distinguished from the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The diagnosis of the other <z:e sem="disease" ids="C0949690" disease_type="Disease or Syndrome" abbrv="">spondyloarthritides</z:e> can be established primarily or later on follow-up, based on further characteristic symptoms and findings </plain></SENT>
<SENT sid="6" pm="."><plain>In the differential diagnosis of <z:hpo ids='HP_0001369'>arthritis</z:hpo> in children, one third do have a <z:e sem="disease" ids="C0949690" disease_type="Disease or Syndrome" abbrv="">spondyloarthritis</z:e> and about one half do have <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>This differentiation is of an important therapeutic and prognostic value, e.g. the slow-acting drugs are effective in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e> but not in <z:e sem="disease" ids="C0949690" disease_type="Disease or Syndrome" abbrv="">spondyloarthritis</z:e>, and in patients with axial manifestations, the early education and training for correct posture is important to prevent the development of <z:hpo ids='HP_0002808'>kyphosis</z:hpo> </plain></SENT>
</text></document>